AN2 Therapeutics, Inc.
ANTX
$5.73
-$0.25-4.18%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 78.39M | 85.29M | 58.00M | 61.92M | 62.92M |
| Total Receivables | 300.00K | 1.00M | 900.00K | 600.00K | 400.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.30M | 1.20M | 1.04M | 1.50M | 4.21M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 79.99M | 87.49M | 59.94M | 64.02M | 67.52M |
|
|
|||||
| Total Current Assets | 79.99M | 87.49M | 59.94M | 64.02M | 67.52M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 216.00K | -- | -- | -- | -- |
| Total Assets | 81.68M | 87.49M | 61.95M | 67.24M | 75.83M |
|
|
|||||
| Total Accounts Payable | 1.97M | 2.62M | 3.02M | 2.23M | 2.11M |
| Total Accrued Expenses | 2.84M | 2.38M | 4.47M | 4.45M | 4.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 776.00K | 567.00K | 1.23M | 183.00K | 717.00K |
| Total Other Current Liabilities | 776.00K | 567.00K | 1.23M | 183.00K | 717.00K |
| Total Current Liabilities | 5.59M | 5.56M | 8.72M | 6.86M | 6.98M |
|
|
|||||
| Total Current Liabilities | 5.59M | 5.56M | 8.72M | 6.86M | 6.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 170.00K | 170.00K | 170.00K | -- | -- |
| Total Liabilities | 5.76M | 5.73M | 8.89M | 6.86M | 6.98M |
|
|
|||||
| Common Stock & APIC | 335.11M | 332.74M | 293.95M | 292.55M | 291.70M |
| Retained Earnings | -259.16M | -250.98M | -240.95M | -232.24M | -222.89M |
| Treasury Stock & Other | -23.00K | -5.00K | 57.00K | 64.00K | 25.00K |
| Total Common Equity | 75.92M | 81.76M | 53.06M | 60.38M | 68.84M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 75.92M | 81.76M | 53.06M | 60.38M | 68.84M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 75.92M | 81.76M | 53.06M | 60.38M | 68.84M |
|
|
|||||